Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Vladimir Torchilin

Vladimir Torchilin

Northeastern University, USA

Title: What properties should nanopreparations possess to become effective anticancer medicines?

Biography

Biography: Vladimir Torchilin

Abstract

Tumor therapy, especially in the case of multidrug resistant cancers, could be significantly enhanced by using siRNA down-regulating the production of proteins, which are involved in cancer cell resistance, such as Pgp or survivin. Even better response could be achieved such as siRNA could be delivered to tumors together with chemotherapeutic agent. This task is complicated by low stability of siRNA in biological surrounding. Thus, the delivery system should simultaneously protect siRNA from degradation. Additionally, these nano preparations can be loaded into their lipidic core with poorly water soluble chemotherapeutic agents, such as paclitaxel or camptothecin. In experiments with cancer cell monolayers, cancer cell 3D spheroids, and in animals with implanted tumors, it was shown that such co-loaded preparations can significantly down-regulate target proteins in cancer cells, enhance drug activity, and reverse multidrug resistance. In order to specifically unload such nano preparations inside tumors, we made them sensitive to local tumor-specific stimuli, such as lowered pH, hypoxia, or overexpressed certain enzymes, such as matrix metalloproteases. Using pH-, hypoxia-, or MMP2-sensitive bonds between different components of nano preparations co-loaded with siRNA and drugs, we were able to make the systems specifically delivering biologically active agents in tumors, which resulted in significantly improved therapeutic response.

<span style="font-size: 12pt; font-family: " times="" new="" roman",="" serif;="" tumor="" therapy,="" especially="" in="" the="" case="" of="" multidrug="" resistant="" cancers,="" could="" be="" significantly="" enhanced="" by="" using="" sirna="" down-regulating="" production="" proteins,="" which="" are="" involved="" cancer="" cell="" resistance,="" such="" as="" pgp="" or="" survivin.="" even="" better="" response="" achieved="" delivered="" to="" tumors="" together="" with="" chemotherapeutic="" agent.="" this="" task="" is="" complicated="" low="" stability="" biological="" surrounding.="" thus,="" delivery="" system="" should="" simultaneously="" protect="" from="" degradation.="" additionally,="" these="" nano="" preparations="" can="" loaded="" into="" their="" lipidic="" core="" poorly="" water="" soluble="" agents,="" paclitaxel="" camptothecin.="" experiments="" monolayers,="" 3d="" spheroids,="" and="" animals="" implanted="" tumors,="" it="" was="" shown="" that="" co-loaded="" down-regulate="" target="" proteins="" cells,="" enhance="" drug="" activity,="" reverse="" resistance.="" order="" specifically="" unload="" inside="" we="" made="" them="" sensitive="" local="" tumor-specific="" stimuli,="" lowered="" ph,="" hypoxia,="" overexpressed="" certain="" enzymes,="" matrix="" metalloproteases.="" ph-,="" hypoxia-,="" mmp2-sensitive="" bonds="" between="" different="" components="" drugs,="" were="" able="" make="" systems="" delivering="" biologically="" active="" agents="" resulted="" improved="" therapeutic="" response.